Help Solve Chronic Lower Back Pain
ENSO is conducting a study around a drug-free treatment and coaching program. Learn how you could help us to evaluate a new treatment for severe forms of chronic back pain.
The vast majority of users (89%) reported clinically significant levels of pain reduction
Users experienced 36% improvement in mobility after 4 weeks of using the device
Opioid Use Reduction
More than 62% of respondents reported a 50% or greater reduction in their opioid use
A COMPREHENSIVE SOLUTION FOR CHRONIC PAIN
A COMPREHENSIVE SOLUTION FOR CHRONIC PAIN
Wearable Pain Relief
A novel non-invasive neuromodulation device that helps manage chronic pain. 100% drug-free, lightweight, and comfortable for all-day use.
ENSO provides patients with a dedicated coach to answer questions, offer feedback, and provide support towards goals.
Results are tracked and regular reports are provided to healthcare providers.
FDA CLEARED TO MANAGE CHRONIC PAIN
NON-INVASIVE NEUROMODULATION HOLDS PROMISE AS THE FUTURE OF PAIN MANAGEMENT
The ENSO neuromodulation device delivers electrical pulses across the skin to suppress the activity of nerves in the area where it is applied.
The technology behind ENSO is based on the latest breakthroughs in neuroscience research. Proprietary waveforms deliver a novel mechanism of action for nerve signal modulation.
“I’ve been battling lower back pain for years, getting injections helps for a few weeks but it doesn’t last. I refuse to take opioids for all the obvious downsides, and I’m also weary of surgery. Nowadays, I use ENSO every morning and at night. I’ve never slept better.”
EDWARD, 49, MEDICAL DEVICE EXECUTIVE
“I can’t thank my doctor enough for getting me into the ENSO clinical study. The treatment is absolutely amazing, and it has lowered my pain level at least 30% so far. Best of all, I’m able to take less Percocet, which had been the worst struggle until now.”
MONICA, 73, RETIRED JEWELRY MAKER
“I’ve been dealing with non-specific low back pain of mild to moderate intensity for the past 5 years and have tried a ton of different things that didn’t help. ENSO is one of the few things that has had a lasting impact. It’s an important tool to keep me functioning at the level I want to reach my personal and professional goals.”
JULIAN, 29, PRESIDENT OF CANVAS MEDICAL
ENSO CASE STUDY
Dr. William Brose
Dr. William Brose is the founder of Stanford University’s pain management program. He focuses on treating debilitating forms of chronic pain and opioid dependence. His aim is to reduce disability and improve quality of life for his patients.
Dr. Brose uses the ENSO pain management program as an alternative to medication-based therapy in order to reduce opioid use and restore physical function for his patients. His patients so far have experienced reduce dependence on medication and increased ability to exercise and perform other daily functional tasks.
“ENSO is a great solution for reducing pain and restoring functionality for people with chronic pain that do not want to deal with the harmful effects of pain medications. The program is clinically based on reducing their intake of pain medications and helping patients achieve their lifestyle goals.”
Dr. Jeff Wayne
Clinical Trials Research (CTR)
”For the past 25 years, I’ve maintained a private internal medicine practice and clinical trials program. During that time, I have provided medical care and conducted research studies for numerous patients with chronic pain. My experience utilizing the ENSO device for chronic back pain patients has been positive. We have consistently seen improved pain and function in our patients, as well as a decrease in their need for pain medications including opioids. I am excited and encouraged that we have a simple and safe modality to help our patients with chronic pain.”
Dr. Francisco Garcia
”I have been particularly impressed by the ENSO device. Patients we selected had significant chronic pain issues and my expectations were not high as these patients were on chronic opiates and had significant limitations. Nearly immediately, their mobility and posture improved. Quality of life significantly improved allowing them to more fully participate in their ADL’s. I have no qualms recommending use of this device in our patient population.”